Ledger.Open graph →

SEC Form D · filed February 21, 2014

Bellerophon Therapeutics LLC

Offering

$1

Sold

$1

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

HAMPTON, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Andre Moura · Hampton, NJDirector Robert Nelsen · Hampton, NJDirector Adam Weinstein · Hampton, NJDirector Aldo Belloni · Hampton, NJDirector Daniel Tasse · Hampton, NJExec · Director Martin Meglasson · Hampton, NJExec Howard Pien · Hampton, NJDirector Reinilde Heyrman · Hampton, NJExec David Abrams · Hampton, NJExec Manesh Naidu · Hampton, NJExec Matthew Holt · New York, NYDirector Bryan Roberts · Fort Washington, PADirector David D. Ritter · Atlanta, GADirector David R. Emerson · Atlanta, GADirector Scott M. Freeman · Atlanta, GADirector John W. Burgin · Atlanta, GADirector James Huff · Juno Beach, FLExec · Director Alexander Weiss · Juno Beach, FLExec Steven R. Major · New York, NYDirector Jay R. Petschek · NEW YORK, NYExec Leo Lagrotte · Carmel, INExec David W. Freelove · New York, NYExec Jonathan Abodeely · Burlington, VTDirector Bryan Roberts · Hampton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗